Treatment of Postobstructive Pneumonia

Initial Assessment and Management

The American College of Emergency Physicians recommends prompt administration of antibiotics, with the first dose given in the emergency department for hospitalized patients 1
Severity assessment should guide the decision between outpatient versus inpatient treatment, according to the Infectious Diseases Society of America 2

For hospitalized patients with non-severe postobstructive pneumonia, the British Thoracic Society recommends combined therapy with a β-lactam plus a macrolide 3, 4
For severe postobstructive pneumonia requiring ICU admission, the Infectious Diseases Society of America recommends intravenous combination of a broad-spectrum β-lactamase stable antibiotic plus either azithromycin or a fluoroquinolone 4
The British Thoracic Society suggests that for patients intolerant to β-lactams or macrolides, a respiratory fluoroquinolone can be used 3

For non-severe pneumonia without identified pathogens, the Infectious Diseases Society of America recommends 7-10 days of treatment 5
For severe pneumonia, the British Thoracic Society recommends a minimum of 10 days of treatment 3
Treatment should be extended to 14-21 days when legionella, staphylococcal, or gram-negative enteric bacilli are suspected or confirmed, according to the British Thoracic Society 3
Patients should be treated for a minimum of 5 days, should be afebrile for 48-72 hours, and should have no more than 1 CAP-associated sign of clinical instability before discontinuation of therapy, as recommended by the Infectious Diseases Society of America 1

The Infectious Diseases Society of America recommends transitioning from intravenous to oral antibiotics when patients are hemodynamically stable and improving clinically, able to ingest medications, and have a normally functioning gastrointestinal tract 1
Early switch to oral therapy can reduce length of hospital stay, according to the Infectious Diseases Society of America 1

The British Thoracic Society suggests that for patients who fail to improve as expected, a thorough review of clinical history, examination, and all available investigation results should be conducted 3
Consider further investigations including repeat chest radiograph, inflammatory markers, and additional microbiological testing, as recommended by the British Thoracic Society 3

The Infectious Diseases Society of America recommends arranging follow-up chest radiograph at around 6 weeks, especially for patients over 50 years who are smokers, due to higher risk of underlying malignancy 5

The American Thoracic Society recommends administering a β-lactam (such as amoxicillin-clavulanate, ceftriaxone, or cefotaxime) plus a macrolide (azithromycin or clarithromycin) as first-line empirical therapy for patients with post-obstructive pneumonia, providing coverage for Streptococcus pneumoniae, Haemophilus influenzae, and atypical pathogens 6, 7.
For severe cases requiring ICU admission, the American College of Chest Physicians suggests using intravenous combination therapy with a broad-spectrum β-lactam (ceftriaxone, cefotaxime, or piperacillin-tazobactam) plus either azithromycin or a fluoroquinolone 8.

The American College of Emergency Physicians recommends administering the first antibiotic dose within 8 hours of hospital arrival, or immediately in the emergency department for hospitalized patients, as earlier administration is associated with improved outcomes in severe pneumonia 6.

The Infectious Diseases Society of America notes that prior antibiotic use strongly predicts the causative pathogen, with gram-positive cocci and H. influenzae being more common without prior antibiotics, while non-fermentative gram-negative bacilli (including Pseudomonas) are associated with previous antibiotic exposure 9.

The British Thoracic Society suggests monitoring temperature, respiratory rate, pulse, blood pressure, mental status, oxygen saturation, and inspired oxygen concentration at least twice daily, more frequently in severe cases, and measuring C-reactive protein (CRP) and repeating chest radiograph in patients not progressing satisfactorily 7.
The American Thoracic Society recommends not changing antibiotics in the first 72 hours unless there is marked clinical deterioration 6.